| Accession | SAMC1834224 |
|---|---|
| Accession in Other Database | GSA-Human: HRS265437 |
| Sample name | C1904978-CTC1 |
| Title | NGS of NSCLC |
| Sample type | Human sample |
| Organism | Homo sapiens |
| Description | C1904978-CTC1 |
| Attributes | *This sample record contains additional controlled-access information that is avaiable from GSA-Human by requesting study HRA001083 in the GSA-Human system. |
| Release date | 2021-07-30 |
| BioProject Accession | PRJCA005546 |
| Submitter | Rong Li (xkyylirong@163.com) |
| Organization | Shanghai Chest Hospital |
| Submission date | 2023-06-18 |
| Resource name | Description |
|---|---|
| GSA-Human (1) | - |
| HRA001083 (Controlled Access) | Circulating tumor cells (CTCs) have important applications in clinical practice on early tumor diagnosis, prognostic prediction and treatment evaluation. Platinum-based chemotherapy is a fundamental treatment for non-small cell lung cancer (NSCLC) patients who are not suitable for targeted drug therapies. However, most patients progressed after a period of treatment. Therefore, to reveal the genetic information contributing to drug resistance and tumor metastasis in CTCs is valuable for treatment adjustment. |